Loading clinical trials...
Loading clinical trials...
Single Arm, Two Phase, Multicenter Clinical Trial to Evaluating the Efficacy and Safety of the CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma
Conditions
Interventions
CD19-targeted CAR-T cells
Locations
1
China
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Start Date
July 2, 2015
Primary Completion Date
July 1, 2019
Completion Date
July 1, 2019
Last Updated
March 23, 2017
NCT06263491
NCT05529069
NCT07388563
NCT06337318
NCT05139017
NCT07350863
Lead Sponsor
Sinobioway Cell Therapy Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions